Save the Date: Bonum will be at #BIO2025! ?? Join our own Neela Patel and industry peers for “Beyond ADCs and Bispecifics: Conditionally Active Biologics," on June 18 at 10:15 AM. Moderator: · Michael Rice, MS, MBA, Expert Advisor, SPV, Cell and Gene Therapy, Lumanity Panelists: · Alexandra Cantley, PhD, Partner, Polaris Partners · Stephen Demarest, PhD, CSO, Tentarix Biotherapeutics · Randi Isaacs, MD, CMO, Werewolf Therapeutics · Neela Patel, PhD, CBO, Bonum Therapeutics · Emmett Schmidt, VP, Clinical Development, Merck See you there! #TheWorldCantWait Biotechnology Innovation Organization
关于我们
Bonum Therapeutics is focused on a proven technology that utilizes regulation to create targeted, highly active, and less toxic medicines.
- 网站
-
https://bonumtx.com
Bonum Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Seattle，WA
- 类型
- 私人持股
- 创立
- 2021
地点
-
主要
获取路线
1616 Eastlake Avenue E
Suite 400
US，WA，Seattle，98102
Bonum Therapeutics员工
动态
-
Today, we proudly celebrate the 10th anniversary of the International Day of Women and Girls in Science! At Bonum Therapeutics, we recognize the critical role that women and girls play in science and technology each and every day. ???? #WomenInScience #GirlsInStem #Steminist
-
-
As we close out January, we're revisiting a remarkable event that took place earlier this month: “In the Pink” at #JPM2025, celebrating the contributions of women leaders in biotech and pharma—and their allies. Can you spot Bonum's own CBO Neela Patel and VP of Preclinical Development Cindy Lai Yee in the #SeaOfPink? Thanks to Biotech CEO Sisterhood, #Breaking7%, and Cooley LLP for sponsoring! #ProjectMirror #WomenInLeadership
-
-
Bonum's Linda Liang, Senior Director of Antibody Discovery, is featured in this month's Life Science Washington Executive Perspective! Learn more about how Linda and her team are discovering new molecules for therapeutics to revolutionize cancer treatment. ??https://lnkd.in/gJ4RipKA #FindYourBestLifeinWA #BonumTherapeutics
-
-
Bonum Therapeutics today announced the appointment of Samuel Blackman, MD, PhD, to its board of directors as an independent director. A pediatric neuro-oncologist and co-founder of Day One Biopharmaceuticals, Blackman led Day One’s acquisition and development of OJEMDA?, which the FDA approved earlier this year for treatment of the most common form of childhood brain tumors, low-grade glioma. His expertise and guidance will be instrumental in advancing Bonum's programs into the clinic. Please join us in welcoming Sam to the Bonum team! For more on this exciting appointment, read the full release: https://ow.ly/I7yb50UjSSw
-
-
The Bonum team had a fantastic time sharing some of our work and connecting with old friends and new at #SITC24. Thanks to everyone at Society for Immunotherapy of Cancer (SITC) for putting on such a great meeting. Looking forward to next year! From left to right: Louie Naumovski, Diane Hollenbaugh, John Mulligan, Ph.D., Cindy Lai Yee, and Justin Killebrew #Immunotherapy #Cytokines #TargetedTherapeutics
-
-
???? No tricks, only treats in part four of Bonum CEO Neela Patel's conversation with The Biotech Startups Podcast host Jon Chee, including: – The transition from Genentech to Poniard Pharmaceuticals and raising $37 million in Series A financing – Neela's experience leading Good Therapeutics through its transition to Roche and the importance of strategic deal structuring – The mission and focus of Bonum Therapeutics, developing cytokine therapies for oncology with minimized toxicity and improved efficacy – The critical importance of maintaining relationships and building a network throughout your career – Advice for entrepreneurs on finding support and avoiding isolation in leadership roles This episode is packed with insights on navigating the biotech industry, from startup challenges to corporate partnerships, making it a must-listen for anyone in the field! Apple Podcasts: https://lnkd.in/gm3SnHGN Spotify: https://lnkd.in/gE5MUZ2Y Brought to you by Excedr. #biotechnology #LifeSciences #podcast
"[My advice to my younger self] would be to maintain relationships with people over time. I didn't necessarily. I enjoyed my postdoc. I enjoyed the people. There's a handful that I'm still friends with. But I wished that I had known that those people would also be my cohort going forward." In Part 4 of The Biotech Startups Podcast conversation with Bonum Therapeutics Chief Business Officer, Neela Patel, we explore the invaluable lessons learned throughout her career journey and the importance of nurturing professional relationships. In this episode, we cover: – The transition from Genentech to Poniard Pharmaceuticals and raising $37 million in Series A financing – Neela's experience leading Good Therapeutics, Inc. through its transition to Roche and the importance of strategic deal structuring – The mission and focus of Bonum Therapeutics, developing cytokine therapies for oncology with minimized toxicity and improved efficacy – The critical importance of maintaining relationships and building a network throughout your career – Advice for entrepreneurs on finding support and avoiding isolation in leadership roles This episode is packed with insights on navigating the biotech industry, from startup challenges to corporate partnerships, making it a must-listen for anyone in the field. Head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast
-
-
?? How do you create a "democracy of ideas" to foster innovation and collaboration? Bonum CEO Neela Patel shares her strategies with Jon Chee, host of The Biotech Startups Podcast, in Part 3 of a 4-episode series. Head over to Apple Podcasts or Spotify to gain invaluable insights on this, developing a pipeline strategy, and much more: Apple Podcasts: https://apple.co/3zdned3 Spotify: https://spoti.fi/40ohxVx Brought to you by Excedr. #biotechnology #LifeSciences #podcast
"Corporate development is really looking at how you can best both monetize your assets and grow your pipeline. So it's really about your bottom line, your ultimate bottom line... But how do you get there? Do you need to bring things in? Do you need to do some out-licensing? Do you do some collaborations?" In Part 3 of The Biotech Startups Podcast conversation with Bonum Therapeutics Chief Business Officer, Neela Patel, we dive deep into the world of corporate development and its crucial role in biotech success. In this episode, we cover: – The transition from Genentech to Poniard Pharmaceuticals and raising $37 million in Series A financing – Developing pipeline strategy and managing multiple research programs with limited resources – The challenges and opportunities of working in search and evaluation at Abbott and AbbVie – Creating a "democracy of ideas" to foster innovation and external collaboration in large pharma companies – Key factors for startups to consider when seeking partnerships or acquisitions with big pharma This episode is packed with invaluable insights for both startup founders and corporate development professionals in the biotech industry. Head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast
-